Dionisia Quiroga, DO, PhD, FASCO

Thank you so much for this honor!

Volunteering with @ascocancer.bsky.social has been a big joy in my career and happy to continue many future years of service!

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.

Learn more about FASCO distinction: brnw.ch/21wUiSd

Thanks to these wonderful running buddies @drgattimays.bsky.social & @quirogad.bsky.social & @oncoalert.bsky.social for making it all happen!!

Perfect #ASCO25 morning - beautiful Chicago lakeside run with two amazing leaders in breast cancer care and advocacy 🏃‍♀️🙏🏽 @christeeny513.bsky.social @drgattimays.bsky.social @oncoalert.bsky.social @ascocancer.bsky.social

See you next week at #ASCO25 !

@osucccjames.bsky.social @oncodaily.bsky.social

#ASCO25 is right around the corner!
✨With >40K registrants, how can you best stand out of the crowd and make meaningful connections during the conference?✨

Here are some tips for trainees & early-career oncologists:
connection.asco.org/do/networkin...
@ascocancer.bsky.social @ascopost.bsky.social

Today family picture with some of the 87 amazing faculty of our Division of Medical Oncology at The James CCC. Very honored to be part and lead this incredible team!
@OhioStateMedOnc
@OSUCCC_James
@OhioStateMed @drgattimays.bsky.social @stoverlab.bsky.social

Honored and grateful for the opportunity to discuss 3 oral abstracts at #ASCO25 and represent #OSUCCC @osucccjames.bsky.social @osuwexmed.bsky.social #Immunotherapy @sitcancer.bsky.social #PIIO @ascocancer.bsky.social

Sacituzumab + Pembro in ASCENT04 improves Progression Free Survival in Patients With Previously Untreated PD-L1 Metastatic Triple-Negative Breast Cancer #bcsm www.gilead.com/news/news-de... @oncoalert.bsky.social

My hometown 🙏🏽
Vaccinations work; please protect yourself and others

🚨We are hiring Medical Oncologists at @OhioStateMedOnc !

Check the QR code below for the available positions! 3 pathways:
- Physician Scientist
- Clinical Scholar
- Clinical Excellence

Send your applications

@OSUCCC_James @OhioStateMed

From 2010 to 2016 (latest data I have ), NIH research contributed to EVERY drug approved by the FDA

Trump wants to erase DEI. Researchers worry it will upend work on health disparity Cancer researchers working on health disparities say President Trump's actions could hurt rural whites, who lag behind other groups in cancer screening.

Cancer researchers working on health disparities say President Trump's actions could hurt rural whites, who lag behind other groups in cancer screening.

Deadline approaching! The #SITC Women in Cancer Immunotherapy Network Leadership Institute applications close March 24. Don’t miss your opportunity to participate in panel discussions and presentations from experienced female leaders. Learn more here: www.sitcancer.org/professional...

NIH indirects case update:

Hearing ongoing now, and I'll try to live tweet some notable exchanges.

Prior to more detailed arguments, Judge Kelley starts off with a few point questions to both sides:

(I'm paraphrasing here)

Discuss real-world case studies with clinical experts! #SITC’s ACI: Women’s Malignancies program will explore practical insights to apply immunotherapy into clinical practice. Join Feb. 28 for a free CME program. Register now: ow.ly/bTFn50UYy9j
@drgattimays.bsky.social @veredstearns.bsky.social

NIH In Your State - United For Medical Research Select a state on the map to see the impact of NIH funding across America.

In Ohio during FY23 (2022-2023) this was the impact of NIH funding:

$1.01 Billion in grants and contracts
$2.05 Billion in economic support
13,061 jobs supported

This reduction in NIH indirect will decimate research and limit health care advances

www.unitedformedicalresearch.org/nih-in-your-...

1. Today the NIH director issued a new directive slashing overhead rates to 15%.

I want to provide some context on what that means and why it matters.

grants.nih.gov/grants/guide...

Virtual Tumor Board: Maximizing the Potential of Immuno-Oncology in Early TNBC Through Personalized Care Tune in for a deep dive into the evolving landscape of immuno-oncology (IO) in early-stage triple-negative breast cancer (TNBC). Our experts focus on identifying eligible patients for neoadjuvant and ...

Great session with Dr Heather McArthur on treating early stage #TNBC #IO posted on #ReachMD @osuwexmed.bsky.social @osucccjames.bsky.social reachmd.com/programs/cme...

Christian Rolfo: 200 participants at OSU SABCS meeting - OncoDaily Christian Rolfo: 200 participants at OSU SABCS meeting / Breast Cancer, cancer, Christian Rolfo, Daniel Stover, Dionisia Quiroga, fight against cancer, Global

200 participants at OSU SABCS meeting - Christian Rolfo @christianrolfo.bsky.social
@stoverlab.bsky.social
@quirogad.bsky.social

oncodaily.com/blog/237555

#BreastCancer #Cancer #FightAgainstCancer #MedOnc #OncoDaily #Oncology #OSU #SABCSmeeting #Medicine #Health

Dr. Quiroga, we're delighted to have you on the expert panel and look forward to your presentation on immunotherapy for late-stage breast cancer!

Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer - Breast Cancer Research Background Trastuzumab deruxtecan (T-DXd) is FDA-approved for treatment of patients with HER2 positive and HER2-low metastatic breast cancer. Currently, there is limited understanding of pre-treatment...

Happy to share our retrospective study on #pneumonitis risk in patients with #breastcancer who receive #TDXd #Enhertu @stoverlab.bsky.social @osucccjames.bsky.social #bcsm

Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social

ASCO Daily News: Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations Dr. Jessica Sukumar and Dr. Dionisia Quiroga discuss advances in adjuvant therapy for patients with early breast cancer and BRCA1/2 mutations, including how to identify patients who should receive gen...

🎉Reunion w/ my co-fellow @jasminesukumar.bsky.social @mdanderson.bsky.social to discuss early #breastcancer adj tx w/ path germline muts on the @ascocancer.bsky.social Daily News podcast

👉Who needs testing?
👉OLYMPIA updates
👉Concurrent PARPi use w/ other adj tx

ascodaily.libsyn.com/advances-in-...

📚🎙️Come discuss updates and the future of IO use in #MBC with me on Feb 28th!

A++ group of #breastonc #gynonc speakers and great opportunity for CME/MOC and other ed credits
@sitcancer.bsky.social
#LearnACI #bcsm @drgattimays.bsky.social @osucccjames.bsky.social

OSU SABCS meeting - 200 participants in attendance. Great turn out and awesome presentations by our amazing Breast Cancer team. Very proud of them 🙂👏

@OhioStateMedOnc
@StoverLab @quirogad @CherianMathew30 Maggie Gatti-Myes and all team!

#SABCS24
@OSUCCC_James @OhioStateMed

Love working with this group of talented docs! (We are so in sync we color coordinated without planning it #ScarletandGrey) @osucccjames.bsky.social

Annual cancer study shows who could be diagnosed this year Annual cancer study shows who could be diagnosed this year

Great segment on @nbc4i.bsky.social by @stoverlab.bsky.social @osucccjames.bsky.social on the recent #ACS cancer stats www.nbc4i.com/video/annual...

Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring Researchers facing

⏱️ The next cancer cure is on hold.

⁦‪@NIH‬⁩ grants invest in future science gains that pay back for our citizens at a rate of more than 2:1 in economic activity.

We are losing the battle for discovery.

Excellent advocacy program with Living Beyond Breast Cancer (LBBC) specific to patients living with stage IV/metastatic disease! This program was the foundation for my advocacy work and you'll meet some pretty amazing peeps along the way as well ♥️

bit.ly/3tEqyP9